Clinical Trials Directory

Trials / Completed

CompletedNCT03896100

Assessment of Intracellular Cytokines and Markers in Cells (Phase 3)

Assessment of Levels of Intracellular Cytokines and Markers in Cells Recovered From the Anterior Eye (Phase 3)

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a single arm, prospective, bilateral, non-randomized study that will be split into four elements. Element 1 will be an in vitro non-clinical study and described in the laboratory protocol. Elements 2, 3 and 4 will each be a single non-dispensing visit.

Conditions

Timeline

Start date
2019-03-28
Primary completion
2019-09-15
Completion
2019-09-15
First posted
2019-03-29
Last updated
2019-10-16

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03896100. Inclusion in this directory is not an endorsement.